ConductScience.org, home

Paper40775615

Predictive factors for metabolic syndrome in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).

Alnees M and 13 others. BMC Gastroenterol, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Predictive factors for metabolic syndrome in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Papers, record 40775615. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40775615

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Predictive factors for metabolic syndrome in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).
PubMed
Journal
BMC Gastroenterol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-08-11
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alnees MMohammad
2Awwad MMahdi
3Najajra DDuha
4Darwish AAbdalaziz
5Heih OOmar
6Al-Ali TThara
7Hamdeh NANizar Abu
8Abdullah AAli
9Ahmad JJamal
10Jarrar KKawthar
11Al-Ihribat AAlaa
12Salloum OOmar
13Abdoh QQusay
14Khadija HAHaitham Abu

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Metabolic SyndromeMajor topic
Diabetes Mellitus, Type 2Major topic
Fatty LiverMajor topic
Humans
Male
Female
Middle Aged
Cross-Sectional Studies
Retrospective Studies
Waist Circumference
Triglycerides
Risk Factors
Blood Pressure
Cholesterol, HDL
Aged
Adult

Source PubMed

Download CSV of topics

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131063854Risk factors in metabolic syndrome predict the progression of diabetic nephropathy in patients with type 2 diabetes.Diabetes Res Clin Pract2019https://conductscience.org/library/papers/31063854PubMed
232226553Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease.Theranostics2020https://conductscience.org/library/papers/32226553PubMed
338100294Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings.Hepatology2024https://conductscience.org/library/papers/38100294PubMed
427062661EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.J Hepatol2016https://conductscience.org/library/papers/27062661PubMed
538268305Comparing the association of two metabolic syndrome definitions, NCEP ATP III and IDF, with the risk of developing atherosclerotic cardiovascular disease: An analytical cross-sectional study.Endocrinol Diabetes Metab2024https://conductscience.org/library/papers/38268305PubMed
632775749Population-derived cut-off for HbA1c could enhance the identification of metabolic syndrome among non-diabetic population.Heliyon2020https://conductscience.org/library/papers/32775749PubMed
735227957The impact of metabolic health on non-alcoholic fatty liver disease (NAFLD). A single center experience.Clin Res Hepatol Gastroenterol2022https://conductscience.org/library/papers/35227957PubMed
837700494Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review.J Obes Metab Syndr2023https://conductscience.org/library/papers/37700494PubMed
936677012Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs.Metabolites2023https://conductscience.org/library/papers/36677012PubMed
1035283365Hepatic Fibrosis and Steatosis in Metabolic Syndrome.J Obes Metab Syndr2022https://conductscience.org/library/papers/35283365PubMed
1137213404Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications.World J Gastroenterol2023https://conductscience.org/library/papers/37213404PubMed
1237830733Interactions between Metabolic Syndrome, MASLD, and Arterial Stiffening: A Single-Center Cross-Sectional Study.Healthcare (Basel)2023https://conductscience.org/library/papers/37830733PubMed
1336568079Long-term trajectories of BMI and cumulative incident metabolic syndrome: A cohort study.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36568079PubMed
1432696080NAFLD and cardiovascular diseases: a clinical review.Clin Res Cardiol2021https://conductscience.org/library/papers/32696080PubMed
1538927836Precision Non-Alcoholic Fatty Liver Disease (NAFLD) Diagnosis: Leveraging Ensemble Machine Learning and Gender Insights for Cost-Effective Detection.Bioengineering (Basel)2024https://conductscience.org/library/papers/38927836PubMed
1639033292Sustained metabolic dysregulation and the emergence of diabetes: associations between HbA1c and metabolic syndrome components in Tunisian diabetic and nondiabetic groups.J Physiol Anthropol2024https://conductscience.org/library/papers/39033292PubMed
1731686762Ultrasound-based techniques for the diagnosis of liver steatosis.World J Gastroenterol2019https://conductscience.org/library/papers/31686762PubMed
1838498331Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes.Diabetes Care2024https://conductscience.org/library/papers/38498331PubMed
1938202285What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside.J Clin Med2024https://conductscience.org/library/papers/38202285PubMed
2030907828Does Weight Status Impact Metabolic Health in Adolescents When Controlling for Physical Fitness?Pediatr Phys Ther2019https://conductscience.org/library/papers/30907828PubMed

See all 40 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42978133Circulating Estradiol as an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease and Fibrosis Risk in Women: Evidence From a Multicenter Health-Checkup Cohort.J Korean Med Sci2026https://conductscience.org/library/papers/42978133PubMed
42862333Targeting ceramides in metabolic syndrome: recent advances and therapeutic opportunities.Acta Diabetol2026https://conductscience.org/library/papers/42862333PubMed
41612500Multi-strain synbiotic and lifestyle modifications on patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a randomized double-blinded placebo-controlled trial.Eur J Med Res2026https://conductscience.org/library/papers/41612500PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40775615

GET https://conductscience.org/api/papers/v1/40775615/references?page=2